vix.ing · top · new · best · stats · spec

Josef S Smolen

  1. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
    2010/08/10 by Daniel Aletaha, Tuhina Neogi, Alan J. Silman +37 · 46 citations
    Medicine · #Rheumatoid Arthritis Research and Therapies #Spondyloarthritis Studies and Treatments #Musculoskeletal Disorders and Rehabilitation
  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
    2022/11/10 by Josef S Smolen, Robert B M Landewé, Robert Landewé +63 · 42 citations
    Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Hemophilia Treatment and Research
  3. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
    2023/10/12 by Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen +55 · 41 citations
    Medicine · #Systemic Lupus Erythematosus Research #Rheumatoid Arthritis Research and Therapies #Systemic Sclerosis and Related Diseases
  4. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
    2019/03/29 by Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno +33 · 31 citations
    Medicine · #Systemic Lupus Erythematosus Research #Cytokine Signaling Pathways and Interactions #Autoimmune and Inflammatory Disorders Research
  5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
    2020/01/22 by Josef S Smolen, Robert B M Landewé, Robert Landewé +62 · 31 citations
    Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Systemic Lupus Erythematosus Research
  6. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
    2013/10/25 by Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld +44 · 29 citations
    Medicine · Immunology and Microbiology · #Rheumatoid Arthritis Research and Therapies #Biosimilars and Bioanalytical Methods #Lymphoma Diagnosis and Treatment
  7. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
    2016/02/10 by Laure Gossec, L Gossec, J S Smolen +65 · 29 citations
    Medicine · Immunology and Microbiology · #Spondyloarthritis Studies and Treatments #Rheumatoid Arthritis Research and Therapies #Psoriasis: Treatment and Pathogenesis
  8. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
    2020/06/01 by Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer +37 · 29 citations
    Medicine · Immunology and Microbiology · #Spondyloarthritis Studies and Treatments #Rheumatoid Arthritis Research and Therapies #Psoriasis: Treatment and Pathogenesis
  9. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
    2024/03/18 by Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira +46 · 32 citations
    Medicine · Immunology and Microbiology · #Spondyloarthritis Studies and Treatments #Rheumatoid Arthritis Research and Therapies #Psoriasis: Treatment and Pathogenesis
  10. Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity
    2012/07/19 by Paul Studenic, Helga Radner, Josef S Smolen +2 · 26 citations
    Medicine · Health Professions · #Rheumatoid Arthritis Research and Therapies #Health Literacy and Information Accessibility #Patient-Provider Communication in Healthcare
  11. EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update
    2025/10/16 by Antonis Fanouriakis, Myrto Kostopoulou, Hans-Joachim Anders +35 · 27 citations
    Medicine · #Systemic Lupus Erythematosus Research #Rheumatoid Arthritis Research and Therapies #Renal Transplantation Outcomes and Treatments
  12. Differential tissue expression and activation of p38 MAPK α, β, γ, and δ isoforms in rheumatoid arthritis
    2006/08/31 by Adelheid Korb, Makiyeh Tohidast‐Akrad, M Tohidast-Akrad +5 · 25 citations
    Biochemistry, Genetics and Molecular Biology · Medicine · #Melanoma and MAPK Pathways #NF-κB Signaling Pathways #Cytokine Signaling Pathways and Interactions
  13. Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statement
    2025/02/10 by Victoria Konzett, Josef S. Smolen, Josef S Smolen +15 · 7 citations
    Medicine · #Rheumatoid Arthritis Research and Therapies #Spondyloarthritis Studies and Treatments #Cytokine Signaling Pathways and Interactions